Chemicals

Showing 36301–36450 of 41137 results

  • Spinosyn A 17-pseudoaglycone is a pseudoaglycone form of the macrocyclic lactone insecticide spinosyn A (Item No. 16528).{43158} Unlike spinosyn A, spinosyn A 17-pseudoaglycone is not lethal to tobacco budworm (H. virescens) neonate larvae (LC50 = >64 ppm).  

     

    Brand:
    Cayman
    SKU:25530 - 1 mg

    Available on backorder

  • Spinosyn A 17-pseudoaglycone is a pseudoaglycone form of the macrocyclic lactone insecticide spinosyn A (Item No. 16528).{43158} Unlike spinosyn A, spinosyn A 17-pseudoaglycone is not lethal to tobacco budworm (H. virescens) neonate larvae (LC50 = >64 ppm).  

     

    Brand:
    Cayman
    SKU:25530 - 5 mg

    Available on backorder

  • Spinosyn A aglycone is an aglycone form of the insecticide spinosyn A.{45038} It is formed by acid hydrolysis of spinosyn A 17-pseudoaglycone (Item No. 25530). Spinosyn A aglycone has no insecticidal activity at concentrations up to 64 ppm.  

     

    Brand:
    Cayman
    SKU:27992 - 1 mg

    Available on backorder

  • Spinosyn A aglycone is an aglycone form of the insecticide spinosyn A.{45038} It is formed by acid hydrolysis of spinosyn A 17-pseudoaglycone (Item No. 25530). Spinosyn A aglycone has no insecticidal activity at concentrations up to 64 ppm.  

     

    Brand:
    Cayman
    SKU:27992 - 5 mg

    Available on backorder

  • Spinosyn D is a spinosoid that is a minor component of spinosad, an insecticide based on chemical compounds found in a bacterial species isolated from sugarcane, S. spinosa.{26993} It acts as an agonist of insect nicotinic acetylcholinesterase receptors.{26993} Spinosyn D demonstrates insecticidal activity against H. virescens larvae (tobacco budworm) with an LD50 value of 0.8 ppm.{26992}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Spinosyn D is a spinosoid that is a minor component of spinosad, an insecticide based on chemical compounds found in a bacterial species isolated from sugarcane, S. spinosa.{26993} It acts as an agonist of insect nicotinic acetylcholinesterase receptors.{26993} Spinosyn D demonstrates insecticidal activity against H. virescens larvae (tobacco budworm) with an LD50 value of 0.8 ppm.{26992}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Spinosyn D 17-pseudoaglycone is a hydrolysis product of the minor insecticide component spinosyn D (Item No. 19158).{45038} Unlike spinosyn D, spinosyn D 17-pseudoaglycone is not lethal to tobacco budworms (H. virescens) when used at concentrations up to 64 ppm.  

     

    Brand:
    Cayman
    SKU:27975 - 2.5 mg

    Available on backorder

  • Spinosyn D 17-pseudoaglycone is a hydrolysis product of the minor insecticide component spinosyn D (Item No. 19158).{45038} Unlike spinosyn D, spinosyn D 17-pseudoaglycone is not lethal to tobacco budworms (H. virescens) when used at concentrations up to 64 ppm.  

     

    Brand:
    Cayman
    SKU:27975 - 500 µg

    Available on backorder

  • Spinosyn D aglycone is an aglycone form of the insecticide spinosyn D (Item No. 19158).{42776} Unlike spinosyn D, spinosyn D aglycone is not lethal to H. virescens (tobacco budworm) neonate larvae (LC50 = >64 ppm).  

     

    Brand:
    Cayman
    SKU:27937 - 2.5 mg

    Available on backorder

  • Spinosyn D aglycone is an aglycone form of the insecticide spinosyn D (Item No. 19158).{42776} Unlike spinosyn D, spinosyn D aglycone is not lethal to H. virescens (tobacco budworm) neonate larvae (LC50 = >64 ppm).  

     

    Brand:
    Cayman
    SKU:27937 - 500 µg

    Available on backorder

  • Spiramycin is a 16-membered macrolide antibiotic with anti-parasitic actions. Like other macrolides, spiramcyin inhibits microbial protein synthesis.{22680} It is effective against the parasitic protozoan T. gondii in clinical trials.{32005}  

     

    Brand:
    Cayman
    SKU:20267 -

    Available on backorder

  • Spiramycin is a 16-membered macrolide antibiotic with anti-parasitic actions. Like other macrolides, spiramcyin inhibits microbial protein synthesis.{22680} It is effective against the parasitic protozoan T. gondii in clinical trials.{32005}  

     

    Brand:
    Cayman
    SKU:20267 -

    Available on backorder

  • Spiramycin is a 16-membered macrolide antibiotic with anti-parasitic actions. Like other macrolides, spiramcyin inhibits microbial protein synthesis.{22680} It is effective against the parasitic protozoan T. gondii in clinical trials.{32005}  

     

    Brand:
    Cayman
    SKU:20267 -

    Available on backorder

  • Spiro-MeOTAD is a stable and efficient hole-transport material in organic light-emitting devices and in solid-state dye-sensitized solar cells (ssDSSCs).{28348} It yields higher ssDSSC efficiency compared to the liquid electrolyte for DSSC solar cells due to its reasonable charge carrier mobility and its amorphous nature and high solubility, which enables excellent infiltration into mesoporous titania films.{28348} Neutral spiro-MeOTAD absorbs light in the UV region of the spectrum, while its oxidized forms exhibit strong absorptions throughout the visible and near-infrared ranges.{28348}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Spiro-MeOTAD is a stable and efficient hole-transport material in organic light-emitting devices and in solid-state dye-sensitized solar cells (ssDSSCs).{28348} It yields higher ssDSSC efficiency compared to the liquid electrolyte for DSSC solar cells due to its reasonable charge carrier mobility and its amorphous nature and high solubility, which enables excellent infiltration into mesoporous titania films.{28348} Neutral spiro-MeOTAD absorbs light in the UV region of the spectrum, while its oxidized forms exhibit strong absorptions throughout the visible and near-infrared ranges.{28348}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Spiro-MeOTAD is a stable and efficient hole-transport material in organic light-emitting devices and in solid-state dye-sensitized solar cells (ssDSSCs).{28348} It yields higher ssDSSC efficiency compared to the liquid electrolyte for DSSC solar cells due to its reasonable charge carrier mobility and its amorphous nature and high solubility, which enables excellent infiltration into mesoporous titania films.{28348} Neutral spiro-MeOTAD absorbs light in the UV region of the spectrum, while its oxidized forms exhibit strong absorptions throughout the visible and near-infrared ranges.{28348}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Spiro-MeOTAD is a stable and efficient hole-transport material in organic light-emitting devices and in solid-state dye-sensitized solar cells (ssDSSCs).{28348} It yields higher ssDSSC efficiency compared to the liquid electrolyte for DSSC solar cells due to its reasonable charge carrier mobility and its amorphous nature and high solubility, which enables excellent infiltration into mesoporous titania films.{28348} Neutral spiro-MeOTAD absorbs light in the UV region of the spectrum, while its oxidized forms exhibit strong absorptions throughout the visible and near-infrared ranges.{28348}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Spiro-oxanthromicin A is a polyketide that has been found in Streptomyces.{38316} It induces mislocalization of K-RAS in MDCK cells (IC50 = 26.7 µM).  

     

    Brand:
    Cayman
    SKU:32555 - 100 µg

    Available on backorder

  • Spiro-oxanthromicin A is a polyketide that has been found in Streptomyces.{38316} It induces mislocalization of K-RAS in MDCK cells (IC50 = 26.7 µM).  

     

    Brand:
    Cayman
    SKU:32555 - 500 µg

    Available on backorder

  • Spirohexenolide A is a metabolite originally isolated from S. platensis.{42121} It inhibits growth in the NCI-60 cancer cell line panel (GI50s = 0.1-17 μM) with the RPMI-8226 multiple myeloma, HOP-92 lung, and SW620 colon cancer cell lines being most sensitive (GI50s = 254, 191, and 565 nM, respectively). Spirohexenolide A also binds to human macrophage migration inhibition factor (MIF; Kd = 35.9 μM) and inhibits MIF cellular uptake and lysosomal localization in HCT116 cells.{42122}  

     

    Brand:
    Cayman
    SKU:25116 - 100 µg

    Available on backorder

  • Spirohexenolide A is a metabolite originally isolated from S. platensis.{42121} It inhibits growth in the NCI-60 cancer cell line panel (GI50s = 0.1-17 μM) with the RPMI-8226 multiple myeloma, HOP-92 lung, and SW620 colon cancer cell lines being most sensitive (GI50s = 254, 191, and 565 nM, respectively). Spirohexenolide A also binds to human macrophage migration inhibition factor (MIF; Kd = 35.9 μM) and inhibits MIF cellular uptake and lysosomal localization in HCT116 cells.{42122}  

     

    Brand:
    Cayman
    SKU:25116 - 500 µg

    Available on backorder

  • Spirolaxine is a long-chain phthalide produced by the fungus S. laxum that has antibacterial properties.{34604,34610} Spirolaxine is a potent anti-H. pylori agent (MIC = 0.2 µg/cm3) with weak activity against E. coli.{34610,34608} Spirolaxine (1-40 µM) inhibits proliferation of endothelial (BMEC, HUVEC) and tumor (LoVo, HL-60) cells in culture.{34607} B. megaterium and C. echinulate produce hydroxylated metabolites of spirolaxine when given spirolaxine as a substrate.{34605}  

     

    Brand:
    Cayman
    SKU:22063 -

    Out of stock

  • Spirolaxine is a long-chain phthalide produced by the fungus S. laxum that has antibacterial properties.{34604,34610} Spirolaxine is a potent anti-H. pylori agent (MIC = 0.2 µg/cm3) with weak activity against E. coli.{34610,34608} Spirolaxine (1-40 µM) inhibits proliferation of endothelial (BMEC, HUVEC) and tumor (LoVo, HL-60) cells in culture.{34607} B. megaterium and C. echinulate produce hydroxylated metabolites of spirolaxine when given spirolaxine as a substrate.{34605}  

     

    Brand:
    Cayman
    SKU:22063 -

    Out of stock

  • Spiromesifen is an insecticide and acaricide that reduces lipid biosynthesis via inhibition of acetyl-CoA carboxylase.{43346,43347} It inhibits chitinase from Egyptian cotton leafworm (S. littoralis) larvae (IC50s = 0.60 and 0.72 μM for enzyme isolated from lab and field strains, respectively).{43348} It induces toxicity in whitefly (T. vaporariorum) nymphs (LC50 = 0.61 mg/L), spider mite (T. cinnabarinus) eggs (LC50 = 0.16 mg/kg), and second instar larvae of S. littoralis lab and field strains (LC50s = 0.44 and 0.68 ppm, respectively, at 72 hours post-application).{43346,43347,43348} Spiromesifen (600 mg/kg) also induces 50, 60, and 70% mortality in the Lepidoptera pests H. armigera, O. nubilalis, and P. xylostella, respectively, and induces 100% mortality in M. separata when used at a dose of 100 mg/kg.{43347} It induces toxicity in D. magna (EC50 = >0.092 mg a.s./L) and the fish species O. mykiss and L. macrochirus (LC50s = 0.016 and >0.034 mg a.s./L, respectively) but not rats (LD50 = >2,000 mg/kg).{43350} Spiromesifen also inhibits the human GST isozyme GSTA1-1 (IC50 = 12.1 μM).{43349}  

     

    Brand:
    Cayman
    SKU:25822 - 100 mg

    Available on backorder

  • Spiromesifen is an insecticide and acaricide that reduces lipid biosynthesis via inhibition of acetyl-CoA carboxylase.{43346,43347} It inhibits chitinase from Egyptian cotton leafworm (S. littoralis) larvae (IC50s = 0.60 and 0.72 μM for enzyme isolated from lab and field strains, respectively).{43348} It induces toxicity in whitefly (T. vaporariorum) nymphs (LC50 = 0.61 mg/L), spider mite (T. cinnabarinus) eggs (LC50 = 0.16 mg/kg), and second instar larvae of S. littoralis lab and field strains (LC50s = 0.44 and 0.68 ppm, respectively, at 72 hours post-application).{43346,43347,43348} Spiromesifen (600 mg/kg) also induces 50, 60, and 70% mortality in the Lepidoptera pests H. armigera, O. nubilalis, and P. xylostella, respectively, and induces 100% mortality in M. separata when used at a dose of 100 mg/kg.{43347} It induces toxicity in D. magna (EC50 = >0.092 mg a.s./L) and the fish species O. mykiss and L. macrochirus (LC50s = 0.016 and >0.034 mg a.s./L, respectively) but not rats (LD50 = >2,000 mg/kg).{43350} Spiromesifen also inhibits the human GST isozyme GSTA1-1 (IC50 = 12.1 μM).{43349}  

     

    Brand:
    Cayman
    SKU:25822 - 50 mg

    Available on backorder

  • Spironolactone (Item No. 9000324) is an analytical reference standard categorized as a steroid.{11234,33132} It is a diuretic that has been abused as a performance-enhancing drug and masking agent in sports doping.{33139} This product is intended for research and forensic applications  

     

    Brand:
    Cayman
    SKU:9000324 - 1 mg

    Available on backorder

  • Spironolactone (Item No. 9000324) is an analytical reference standard categorized as a steroid.{11234,33132} It is a diuretic that has been abused as a performance-enhancing drug and masking agent in sports doping.{33139} This product is intended for research and forensic applications  

     

    Brand:
    Cayman
    SKU:9000324 - 5 mg

    Available on backorder

  • Spirotetramat is an insecticide.{42381} It is active against C. pyri nymphs in vitro (LC50 = 6.51-12.53 mg AI/L) and induces mortality of C. pyri nymphs in European pear (P. communis) fields by 99.2% 15 days after application at a concentration of 27 g/hectare. Spirotetramat also reduces O. insidiosus embryonic viability and nymph survival.{42382} It exhibits aquatic toxicity, increasing expression of glutathione peroxidase (Gpx) and superoxide dismutase (SOD), decreasing production of malondialdehyde (MDA), and inducing lethality in Chinese toad (B. gargarizans) tadpoles (LC50 = 6.98 mg/L).{42383}  

     

    Brand:
    Cayman
    SKU:25634 - 100 mg

    Available on backorder

  • Spirotetramat is an insecticide.{42381} It is active against C. pyri nymphs in vitro (LC50 = 6.51-12.53 mg AI/L) and induces mortality of C. pyri nymphs in European pear (P. communis) fields by 99.2% 15 days after application at a concentration of 27 g/hectare. Spirotetramat also reduces O. insidiosus embryonic viability and nymph survival.{42382} It exhibits aquatic toxicity, increasing expression of glutathione peroxidase (Gpx) and superoxide dismutase (SOD), decreasing production of malondialdehyde (MDA), and inducing lethality in Chinese toad (B. gargarizans) tadpoles (LC50 = 6.98 mg/L).{42383}  

     

    Brand:
    Cayman
    SKU:25634 - 25 mg

    Available on backorder

  • Spirotetramat is an insecticide.{42381} It is active against C. pyri nymphs in vitro (LC50 = 6.51-12.53 mg AI/L) and induces mortality of C. pyri nymphs in European pear (P. communis) fields by 99.2% 15 days after application at a concentration of 27 g/hectare. Spirotetramat also reduces O. insidiosus embryonic viability and nymph survival.{42382} It exhibits aquatic toxicity, increasing expression of glutathione peroxidase (Gpx) and superoxide dismutase (SOD), decreasing production of malondialdehyde (MDA), and inducing lethality in Chinese toad (B. gargarizans) tadpoles (LC50 = 6.98 mg/L).{42383}  

     

    Brand:
    Cayman
    SKU:25634 - 50 mg

    Available on backorder

  • Spiroxamine is a tertiary amine fungicide and an inhibitor of Δ14 reductase/Δ8→Δ7 isomerase.{36876} It inhibits the growth of N. parvum, B. dothidea, D. seriata, and L. theobromae isolates from grape vines (EC50s = 0.97-10.28 mg/L).{36877} Spiroxamine (0.03-30 μM) reduces network formation in rat cortical cultures.{36878} It is also cytotoxic to MDA-kb2 cells (EC20 = 9.29 μM).{42005}  

     

    Brand:
    Cayman
    SKU:25823 - 100 mg

    Available on backorder

  • Spiroxamine is a tertiary amine fungicide and an inhibitor of Δ14 reductase/Δ8→Δ7 isomerase.{36876} It inhibits the growth of N. parvum, B. dothidea, D. seriata, and L. theobromae isolates from grape vines (EC50s = 0.97-10.28 mg/L).{36877} Spiroxamine (0.03-30 μM) reduces network formation in rat cortical cultures.{36878} It is also cytotoxic to MDA-kb2 cells (EC20 = 9.29 μM).{42005}  

     

    Brand:
    Cayman
    SKU:25823 - 50 mg

    Available on backorder

  • Active enzyme isolated from bee venom · One unit of enzyme hydrolyzes one µmol of Diheptanoyl Thio-PC per minute at 25°C.  

     

    Brand:
    Cayman
    SKU:60500 - 1 mg

    Available on backorder

  • Active enzyme isolated from bee venom · One unit of enzyme hydrolyzes one µmol of Diheptanoyl Thio-PC per minute at 25°C.  

     

    Brand:
    Cayman
    SKU:60500 - 10 mg

    Available on backorder

  • Active enzyme isolated from bee venom · One unit of enzyme hydrolyzes one µmol of Diheptanoyl Thio-PC per minute at 25°C.  

     

    Brand:
    Cayman
    SKU:60500 - 25 mg

    Available on backorder

  • Active enzyme isolated from bee venom · One unit of enzyme hydrolyzes one µmol of Diheptanoyl Thio-PC per minute at 25°C.  

     

    Brand:
    Cayman
    SKU:60500 - 5 mg

    Available on backorder

  • Secreted phospholipases A2 (sPLA2s) are a diverse family of low molecular weight PLA2s with tissue-specific expression patterns and actions.{23479} The group IIA sPLA2 (sPLA2-IIA) was originally purified from platelets and exudates from patients with rheumatoid arthritis.{23479} Its expression can be induced by inflammatory mediators, and mouse studies suggest that it may play roles in colorectal polyposis, atherosclerosis, and bacterial infections.{23479,23478} sPLA2 inhibitor is an orally active inhibitor of sPLA2-IIA.{28309} It protects against intestinal reperfusion injury in rats when given at 10 mg/kg orally.{28309} sPLA2 inhibitor also attenuates NF-κB signaling in lung cancer cells and protects against diet-induced metabolic syndrome in rats.{28310,28308}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Secreted phospholipases A2 (sPLA2s) are a diverse family of low molecular weight PLA2s with tissue-specific expression patterns and actions.{23479} The group IIA sPLA2 (sPLA2-IIA) was originally purified from platelets and exudates from patients with rheumatoid arthritis.{23479} Its expression can be induced by inflammatory mediators, and mouse studies suggest that it may play roles in colorectal polyposis, atherosclerosis, and bacterial infections.{23479,23478} sPLA2 inhibitor is an orally active inhibitor of sPLA2-IIA.{28309} It protects against intestinal reperfusion injury in rats when given at 10 mg/kg orally.{28309} sPLA2 inhibitor also attenuates NF-κB signaling in lung cancer cells and protects against diet-induced metabolic syndrome in rats.{28310,28308}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Secreted phospholipases A2 (sPLA2s) are a diverse family of low molecular weight PLA2s with tissue-specific expression patterns and actions.{23479} The group IIA sPLA2 (sPLA2-IIA) was originally purified from platelets and exudates from patients with rheumatoid arthritis.{23479} Its expression can be induced by inflammatory mediators, and mouse studies suggest that it may play roles in colorectal polyposis, atherosclerosis, and bacterial infections.{23479,23478} sPLA2 inhibitor is an orally active inhibitor of sPLA2-IIA.{28309} It protects against intestinal reperfusion injury in rats when given at 10 mg/kg orally.{28309} sPLA2 inhibitor also attenuates NF-κB signaling in lung cancer cells and protects against diet-induced metabolic syndrome in rats.{28310,28308}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Secreted phospholipases A2 (sPLA2s) are a diverse family of low molecular weight PLA2s with tissue-specific expression patterns and actions.{23479} The group IIA sPLA2 (sPLA2-IIA) was originally purified from platelets and exudates from patients with rheumatoid arthritis.{23479} Its expression can be induced by inflammatory mediators, and mouse studies suggest that it may play roles in colorectal polyposis, atherosclerosis, and bacterial infections.{23479,23478} sPLA2 inhibitor is an orally active inhibitor of sPLA2-IIA.{28309} It protects against intestinal reperfusion injury in rats when given at 10 mg/kg orally.{28309} sPLA2 inhibitor also attenuates NF-κB signaling in lung cancer cells and protects against diet-induced metabolic syndrome in rats.{28310,28308}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Sporidesmolide is a depsipeptide originally isolated from S. bakeri that has no activity against a variety of bacteria and fungi.{35217,35218}  

     

    Brand:
    Cayman
    SKU:23882 - 2.5 mg

    Available on backorder

  • Sporidesmolide is a depsipeptide originally isolated from S. bakeri that has no activity against a variety of bacteria and fungi.{35217,35218}  

     

    Brand:
    Cayman
    SKU:23882 - 500 µg

    Available on backorder

  • Sporidesmolide II is a cyclic depsipeptide originally isolated from P. chartarum.{42787}  

     

    Brand:
    Cayman
    SKU:28133 - 2.5 mg

    Available on backorder

  • Sporidesmolide II is a cyclic depsipeptide originally isolated from P. chartarum.{42787}  

     

    Brand:
    Cayman
    SKU:28133 - 500 µg

    Available on backorder

  • Sporidesmolide III is a cyclodepsipeptide originally isolated from P. chartarum.{47118}  

     

    Brand:
    Cayman
    SKU:26593 - 2.5 mg

    Available on backorder

  • Sporidesmolide III is a cyclodepsipeptide originally isolated from P. chartarum.{47118}  

     

    Brand:
    Cayman
    SKU:26593 - 500 µg

    Available on backorder

  • Sporidesmolide V is a cyclodepsipeptide fungal metabolite originally isolated from P. chartarum.{39832}  

     

    Brand:
    Cayman
    SKU:25531 - 2.5 mg

    Available on backorder

  • Sporidesmolide V is a cyclodepsipeptide fungal metabolite originally isolated from P. chartarum.{39832}  

     

    Brand:
    Cayman
    SKU:25531 - 500 µg

    Available on backorder

  • Sporogen-AO 1 is a fungal metabolite originally isolated from A. oryzae that has diverse biological activities.{53570,53571,53572,53573,53574} It inhibits HIV-1 Tat transactivation in a cell-based assay with an IC50 value of 15.8 µM.{53573} Sporogen-AO 1 is cytotoxic to HeLa, KB, and NCI H187 cancer cells (IC50s = 8.3, 9, and 5.1 µM, respectively).{53571,53574} It is active against C. albicans (MIC = 4 mM).{53572}  

     

    Brand:
    Cayman
    SKU:29576 - 1 mg

    Available on backorder

  • Sporothriolide is a fungal metabolite that has been found in Sporothrix.{52434} It is active against the plant pathogenic fungi U. violacea, M. microspore, and E. repens, and the alga C. fusca, but not the bacteria B. megaterium and E. coli, when used at a concentration of 10 mg/ml. Sporothriolide inhibits mycelial growth of the plant pathogenic fungus R. solani (EC50 = 3.04 µg/ml) and protects against R. solani-induced rice sheath blight on rice plants when used at a concentration of 200 µg/ml.{52435} It also prevents necrosis induced by the plant pathogenic fungus B. cinerea in pepper seedlings at 500 ppm.{52434} Sporothriolide (4 mg/ml) prevents germination of L. sativum and M. sativa seedlings.  

     

    Brand:
    Cayman
    SKU:29323 - 1 mg

    Available on backorder

  • SPQ is a fluorescent chloride indicator.{43896} Its fluorescence is rapidly quenched by chloride in vitro. It has been used to assess voltage-sensitive chloride transport in placental microvillus vesicles. It has also been used to continuously quantify intracellular calcium efflux induced by parathyroid hormone, forskolin (Item No. 11018), and phorbol 12-myristate 13-acetate (PMA; Item No. 10008014) in isolated human erythrocytes.{43897} In addition, SPQ has been used to determine the type of ion conductance induced by the cystic fibrosis transmembrane conductance regulator (CFTR) in HEK293 cells expressing pTrial10-CRTR2.{43898} SPQ displays excitation maxima of 320 and 350 nm and an emission maximum of 445 nm.{43896}  

     

    Brand:
    Cayman
    SKU:27604 - 100 mg

    Available on backorder

  • SPQ is a fluorescent chloride indicator.{43896} Its fluorescence is rapidly quenched by chloride in vitro. It has been used to assess voltage-sensitive chloride transport in placental microvillus vesicles. It has also been used to continuously quantify intracellular calcium efflux induced by parathyroid hormone, forskolin (Item No. 11018), and phorbol 12-myristate 13-acetate (PMA; Item No. 10008014) in isolated human erythrocytes.{43897} In addition, SPQ has been used to determine the type of ion conductance induced by the cystic fibrosis transmembrane conductance regulator (CFTR) in HEK293 cells expressing pTrial10-CRTR2.{43898} SPQ displays excitation maxima of 320 and 350 nm and an emission maximum of 445 nm.{43896}  

     

    Brand:
    Cayman
    SKU:27604 - 250 mg

    Available on backorder

  • SPQ is a fluorescent chloride indicator.{43896} Its fluorescence is rapidly quenched by chloride in vitro. It has been used to assess voltage-sensitive chloride transport in placental microvillus vesicles. It has also been used to continuously quantify intracellular calcium efflux induced by parathyroid hormone, forskolin (Item No. 11018), and phorbol 12-myristate 13-acetate (PMA; Item No. 10008014) in isolated human erythrocytes.{43897} In addition, SPQ has been used to determine the type of ion conductance induced by the cystic fibrosis transmembrane conductance regulator (CFTR) in HEK293 cells expressing pTrial10-CRTR2.{43898} SPQ displays excitation maxima of 320 and 350 nm and an emission maximum of 445 nm.{43896}  

     

    Brand:
    Cayman
    SKU:27604 - 500 mg

    Available on backorder

  • SPRi 3 is an inhibitor of sepiapterin reductase (SPR), an enzyme that catalyzes the formation of tetrahydrobiopterin (BH4), with IC50 values of 62 and 14 nM for the recombinant human and rat enzymes, respectively.{57061} It is selective for SPR over GTP cyclohydroxylase 1 (GCH1) in primary mouse dorsal root ganglia sensory neurons at 10 µM.{57062} SPRi 3 (50 µM) inhibits proliferation of anti-CD3 and anti-CD28 antibody-stimulated isolated human peripheral blood mononuclear cells (PBMCs) or CD4+ T cells.{57063} Intraperitoneal administration of SPRi 3 (300 mg/kg) decreases brain BH4 levels and reduces mechanical allodynia in mouse models of peripheral neuropathy induced by spared nerve injury (SNI) or chronic constriction injury (CCI).{57062} It also decreases macrophage infiltration and thermal hyperalgesia in the inflamed joints of a mouse model of rheumatoid arthritis induced by complete Freund’s adjuvant (CFA) at the same dose.  

     

    Brand:
    Cayman
    SKU:30950 - 1 mg

    Available on backorder

  • SPRi 3 is an inhibitor of sepiapterin reductase (SPR), an enzyme that catalyzes the formation of tetrahydrobiopterin (BH4), with IC50 values of 62 and 14 nM for the recombinant human and rat enzymes, respectively.{57061} It is selective for SPR over GTP cyclohydroxylase 1 (GCH1) in primary mouse dorsal root ganglia sensory neurons at 10 µM.{57062} SPRi 3 (50 µM) inhibits proliferation of anti-CD3 and anti-CD28 antibody-stimulated isolated human peripheral blood mononuclear cells (PBMCs) or CD4+ T cells.{57063} Intraperitoneal administration of SPRi 3 (300 mg/kg) decreases brain BH4 levels and reduces mechanical allodynia in mouse models of peripheral neuropathy induced by spared nerve injury (SNI) or chronic constriction injury (CCI).{57062} It also decreases macrophage infiltration and thermal hyperalgesia in the inflamed joints of a mouse model of rheumatoid arthritis induced by complete Freund’s adjuvant (CFA) at the same dose.  

     

    Brand:
    Cayman
    SKU:30950 - 5 mg

    Available on backorder

  • SQ 22,536 is an inhibitor of adenylyl cyclase with an IC50 value of 13 μM for inhibition of prostaglandin E1-stimulated increase in cAMP in intact platelets.{20863} It has been used to evaluate adenylyl cyclase activity during iloprost-induced vasorelaxation of isolated pulmonary veins or aorta in several research paradigms, inhibiting cAMP elevation at concentrations of 100-300 μM without effecting relaxation.{20861,20862}  

     

    Brand:
    Cayman
    SKU:-
  • SQ 22,536 is an inhibitor of adenylyl cyclase with an IC50 value of 13 μM for inhibition of prostaglandin E1-stimulated increase in cAMP in intact platelets.{20863} It has been used to evaluate adenylyl cyclase activity during iloprost-induced vasorelaxation of isolated pulmonary veins or aorta in several research paradigms, inhibiting cAMP elevation at concentrations of 100-300 μM without effecting relaxation.{20861,20862}  

     

    Brand:
    Cayman
    SKU:-
  • SQ 22,536 is an inhibitor of adenylyl cyclase with an IC50 value of 13 μM for inhibition of prostaglandin E1-stimulated increase in cAMP in intact platelets.{20863} It has been used to evaluate adenylyl cyclase activity during iloprost-induced vasorelaxation of isolated pulmonary veins or aorta in several research paradigms, inhibiting cAMP elevation at concentrations of 100-300 μM without effecting relaxation.{20861,20862}  

     

    Brand:
    Cayman
    SKU:-
  • SQ 22,536 is an inhibitor of adenylyl cyclase with an IC50 value of 13 μM for inhibition of prostaglandin E1-stimulated increase in cAMP in intact platelets.{20863} It has been used to evaluate adenylyl cyclase activity during iloprost-induced vasorelaxation of isolated pulmonary veins or aorta in several research paradigms, inhibiting cAMP elevation at concentrations of 100-300 μM without effecting relaxation.{20861,20862}  

     

    Brand:
    Cayman
    SKU:-
  • SQ 29,548 is a highly selective TP receptor antagonist which binds to the human recombinant TP receptor with a Ki of 4.1 nM.{8322} It inhibits the aggregation of washed human platelets induced by U-46619 with an IC50 of 0.06 µM.{6643} It antagonizes U-46619 induced contraction of rat and guinea pig tracheal, arterial, and venous smooth muscles with drug/receptor dissociation constants (KB) in the range of 0.5-1.7 nM.{1099} SQ 29,548 also inhibits the contraction of rat vascular smooth muscle induced by 8-iso PGF2α.{955}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • SQ 29,548 is a highly selective TP receptor antagonist which binds to the human recombinant TP receptor with a Ki of 4.1 nM.{8322} It inhibits the aggregation of washed human platelets induced by U-46619 with an IC50 of 0.06 µM.{6643} It antagonizes U-46619 induced contraction of rat and guinea pig tracheal, arterial, and venous smooth muscles with drug/receptor dissociation constants (KB) in the range of 0.5-1.7 nM.{1099} SQ 29,548 also inhibits the contraction of rat vascular smooth muscle induced by 8-iso PGF2α.{955}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • SQ 29,548 is a highly selective TP receptor antagonist which binds to the human recombinant TP receptor with a Ki of 4.1 nM.{8322} It inhibits the aggregation of washed human platelets induced by U-46619 with an IC50 of 0.06 µM.{6643} It antagonizes U-46619 induced contraction of rat and guinea pig tracheal, arterial, and venous smooth muscles with drug/receptor dissociation constants (KB) in the range of 0.5-1.7 nM.{1099} SQ 29,548 also inhibits the contraction of rat vascular smooth muscle induced by 8-iso PGF2α.{955}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Squalene is a biosynthetic precursor to all steroids and a terpene originally isolated from shark liver oil.{45222,45221} Squalene is produced in mammals by condensation of two farnesyl diphosphate molecules by squalene synthase and then oxidized to squalene epoxide for use in the biosynthesis of lanosterol (Item No. 19521), cholesterol, and other steroids.{45222} An oil-in-water emulsion of squalene synergistically increases adaptive immune responses to glucopyranosyl lipid adjuvant (GLA), a toll-like receptor 4 (TLR4) agonist, compared with an aqueous formulation of GLA.{45223} Formulations containing squalene have been used as adjuvants in vaccines and as hair and skin conditioning agents.  

     

    Brand:
    Cayman
    SKU:27058 - 100 g

    Available on backorder

  • Squalene is a biosynthetic precursor to all steroids and a terpene originally isolated from shark liver oil.{45222,45221} Squalene is produced in mammals by condensation of two farnesyl diphosphate molecules by squalene synthase and then oxidized to squalene epoxide for use in the biosynthesis of lanosterol (Item No. 19521), cholesterol, and other steroids.{45222} An oil-in-water emulsion of squalene synergistically increases adaptive immune responses to glucopyranosyl lipid adjuvant (GLA), a toll-like receptor 4 (TLR4) agonist, compared with an aqueous formulation of GLA.{45223} Formulations containing squalene have been used as adjuvants in vaccines and as hair and skin conditioning agents.  

     

    Brand:
    Cayman
    SKU:27058 - 50 g

    Available on backorder

  • SR 0987 is an agonist of the T cell-specific isoform of RORγ (RORγt, retinoic acid receptor-related orphan receptor-γt), inducing reporter gene expression with an EC50 value of ~800 nM.{31062} Stimulation of mouse EL4 T lymphocytes with SR 0987, following activation with PMA (Item No. 10008014) and ionomycin (Item No. 10004974), increases expression of the RORγt target IL-17, while expression of the programmed cell death protein PD-1 is decreased and granzyme B is unchanged.{31062} Decreased cell surface PD-1 protein, assessed by flow cytometry, is observed in a variety of T cells treated with SR 0987.{31062}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • SR 0987 is an agonist of the T cell-specific isoform of RORγ (RORγt, retinoic acid receptor-related orphan receptor-γt), inducing reporter gene expression with an EC50 value of ~800 nM.{31062} Stimulation of mouse EL4 T lymphocytes with SR 0987, following activation with PMA (Item No. 10008014) and ionomycin (Item No. 10004974), increases expression of the RORγt target IL-17, while expression of the programmed cell death protein PD-1 is decreased and granzyme B is unchanged.{31062} Decreased cell surface PD-1 protein, assessed by flow cytometry, is observed in a variety of T cells treated with SR 0987.{31062}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • SR 0987 is an agonist of the T cell-specific isoform of RORγ (RORγt, retinoic acid receptor-related orphan receptor-γt), inducing reporter gene expression with an EC50 value of ~800 nM.{31062} Stimulation of mouse EL4 T lymphocytes with SR 0987, following activation with PMA (Item No. 10008014) and ionomycin (Item No. 10004974), increases expression of the RORγt target IL-17, while expression of the programmed cell death protein PD-1 is decreased and granzyme B is unchanged.{31062} Decreased cell surface PD-1 protein, assessed by flow cytometry, is observed in a variety of T cells treated with SR 0987.{31062}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • SR 0987 is an agonist of the T cell-specific isoform of RORγ (RORγt, retinoic acid receptor-related orphan receptor-γt), inducing reporter gene expression with an EC50 value of ~800 nM.{31062} Stimulation of mouse EL4 T lymphocytes with SR 0987, following activation with PMA (Item No. 10008014) and ionomycin (Item No. 10004974), increases expression of the RORγt target IL-17, while expression of the programmed cell death protein PD-1 is decreased and granzyme B is unchanged.{31062} Decreased cell surface PD-1 protein, assessed by flow cytometry, is observed in a variety of T cells treated with SR 0987.{31062}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Retinoic-acid-receptor-related orphan receptors (ROR) α and γ play a key role in the development of T-helper cells that produce interleukin-17 (TH17 cells), a subset of CD4+ T-cells that contribute to the inflammatory process and have been implicated in the pathology of autoimmune diseases. SR 1001 is a synthetic ligand specific for RORα and RORγ (Kis = 172 and 111 nM, respectively) that functions as an inverse agonist at these receptors.{19493} SR 1001 has been shown to suppress IL-17 promoter driven transcriptional activity by inhibiting the interaction of co-activators such as TRAP220 nuclear receptor box 2 peptide (IC50 = 117 nM) and SRC2 with RORα and RORγ as well as by increasing the recruitment of corepressors such as NCoR. At 5 μM, SR 1001 inhibits TH17 cell differentiation and IL-17A secretion in cultured splenocytes and human PBMCs. A 25 mg/kg dose of SR 1001 twice/day delays the onset and the severity of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.{19493}  

     

    Brand:
    Cayman
    SKU:10922 - 1 mg

    Available on backorder

  • Retinoic-acid-receptor-related orphan receptors (ROR) α and γ play a key role in the development of T-helper cells that produce interleukin-17 (TH17 cells), a subset of CD4+ T-cells that contribute to the inflammatory process and have been implicated in the pathology of autoimmune diseases. SR 1001 is a synthetic ligand specific for RORα and RORγ (Kis = 172 and 111 nM, respectively) that functions as an inverse agonist at these receptors.{19493} SR 1001 has been shown to suppress IL-17 promoter driven transcriptional activity by inhibiting the interaction of co-activators such as TRAP220 nuclear receptor box 2 peptide (IC50 = 117 nM) and SRC2 with RORα and RORγ as well as by increasing the recruitment of corepressors such as NCoR. At 5 μM, SR 1001 inhibits TH17 cell differentiation and IL-17A secretion in cultured splenocytes and human PBMCs. A 25 mg/kg dose of SR 1001 twice/day delays the onset and the severity of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.{19493}  

     

    Brand:
    Cayman
    SKU:10922 - 10 mg

    Available on backorder

  • Retinoic-acid-receptor-related orphan receptors (ROR) α and γ play a key role in the development of T-helper cells that produce interleukin-17 (TH17 cells), a subset of CD4+ T-cells that contribute to the inflammatory process and have been implicated in the pathology of autoimmune diseases. SR 1001 is a synthetic ligand specific for RORα and RORγ (Kis = 172 and 111 nM, respectively) that functions as an inverse agonist at these receptors.{19493} SR 1001 has been shown to suppress IL-17 promoter driven transcriptional activity by inhibiting the interaction of co-activators such as TRAP220 nuclear receptor box 2 peptide (IC50 = 117 nM) and SRC2 with RORα and RORγ as well as by increasing the recruitment of corepressors such as NCoR. At 5 μM, SR 1001 inhibits TH17 cell differentiation and IL-17A secretion in cultured splenocytes and human PBMCs. A 25 mg/kg dose of SR 1001 twice/day delays the onset and the severity of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.{19493}  

     

    Brand:
    Cayman
    SKU:10922 - 25 mg

    Available on backorder

  • Retinoic-acid-receptor-related orphan receptors (ROR) α and γ play a key role in the development of T-helper cells that produce interleukin-17 (TH17 cells), a subset of CD4+ T-cells that contribute to the inflammatory process and have been implicated in the pathology of autoimmune diseases. SR 1001 is a synthetic ligand specific for RORα and RORγ (Kis = 172 and 111 nM, respectively) that functions as an inverse agonist at these receptors.{19493} SR 1001 has been shown to suppress IL-17 promoter driven transcriptional activity by inhibiting the interaction of co-activators such as TRAP220 nuclear receptor box 2 peptide (IC50 = 117 nM) and SRC2 with RORα and RORγ as well as by increasing the recruitment of corepressors such as NCoR. At 5 μM, SR 1001 inhibits TH17 cell differentiation and IL-17A secretion in cultured splenocytes and human PBMCs. A 25 mg/kg dose of SR 1001 twice/day delays the onset and the severity of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.{19493}  

     

    Brand:
    Cayman
    SKU:10922 - 5 mg

    Available on backorder

  • Retinoic acid receptor-related orphan receptors α and γ (RORα and RORγ) have been demonstrated to play important roles in the regulation of metabolism, circadian rhythms, immune function, and tumorigenesis. SR 1078 is a selective agonist of RORα and RORγ that stimulates ROR transcriptional activity in HEK293 cell reporter assays at concentrations as low as 2 µM without effect at the related liver X receptors and farnesoid X receptors.{26889} At 5 µM, SR 1078 has been shown to stabilize p53 and to induce apoptosis in HepG2 cancer cells.{26890}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Retinoic acid receptor-related orphan receptors α and γ (RORα and RORγ) have been demonstrated to play important roles in the regulation of metabolism, circadian rhythms, immune function, and tumorigenesis. SR 1078 is a selective agonist of RORα and RORγ that stimulates ROR transcriptional activity in HEK293 cell reporter assays at concentrations as low as 2 µM without effect at the related liver X receptors and farnesoid X receptors.{26889} At 5 µM, SR 1078 has been shown to stabilize p53 and to induce apoptosis in HepG2 cancer cells.{26890}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Retinoic acid receptor-related orphan receptors α and γ (RORα and RORγ) have been demonstrated to play important roles in the regulation of metabolism, circadian rhythms, immune function, and tumorigenesis. SR 1078 is a selective agonist of RORα and RORγ that stimulates ROR transcriptional activity in HEK293 cell reporter assays at concentrations as low as 2 µM without effect at the related liver X receptors and farnesoid X receptors.{26889} At 5 µM, SR 1078 has been shown to stabilize p53 and to induce apoptosis in HepG2 cancer cells.{26890}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • The receptors for retinoids, RARs and RXRs, induce transcriptional activation by binding the specific retinoid response elements, RARE and RXRE.{24737} Alternatively, retinoid receptors interact with and modulate other transcription factors, including activator protein-1 (AP-1).{24737} SR 11302 is a synthetic retinoid that inhibits AP-1 activity without activating transcription through RARE.{28072} It significantly suppresses both AP-1 activation and phorbol ester-induced papilloma formation in mice when applied topically (0.1 µM).{28073} SR 11302 is used to elucidate the role of AP-1 in various signaling pathways.{28074,28075}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • The receptors for retinoids, RARs and RXRs, induce transcriptional activation by binding the specific retinoid response elements, RARE and RXRE.{24737} Alternatively, retinoid receptors interact with and modulate other transcription factors, including activator protein-1 (AP-1).{24737} SR 11302 is a synthetic retinoid that inhibits AP-1 activity without activating transcription through RARE.{28072} It significantly suppresses both AP-1 activation and phorbol ester-induced papilloma formation in mice when applied topically (0.1 µM).{28073} SR 11302 is used to elucidate the role of AP-1 in various signaling pathways.{28074,28075}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • The receptors for retinoids, RARs and RXRs, induce transcriptional activation by binding the specific retinoid response elements, RARE and RXRE.{24737} Alternatively, retinoid receptors interact with and modulate other transcription factors, including activator protein-1 (AP-1).{24737} SR 11302 is a synthetic retinoid that inhibits AP-1 activity without activating transcription through RARE.{28072} It significantly suppresses both AP-1 activation and phorbol ester-induced papilloma formation in mice when applied topically (0.1 µM).{28073} SR 11302 is used to elucidate the role of AP-1 in various signaling pathways.{28074,28075}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • The receptors for retinoids, RARs and RXRs, induce transcriptional activation by binding the specific retinoid response elements, RARE and RXRE.{24737} Alternatively, retinoid receptors interact with and modulate other transcription factors, including activator protein-1 (AP-1).{24737} SR 11302 is a synthetic retinoid that inhibits AP-1 activity without activating transcription through RARE.{28072} It significantly suppresses both AP-1 activation and phorbol ester-induced papilloma formation in mice when applied topically (0.1 µM).{28073} SR 11302 is used to elucidate the role of AP-1 in various signaling pathways.{28074,28075}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • SR 12343 is a mimetic of the IκB kinase β (IKKβ) NEMO/IKKγ-binding domain (NBD) that inhibits the protein-protein interaction between the IKK complex subunits NF-κB essential modulator (NEMO/IKKγ) and IKKβ.{55404} It selectively disrupts the association of NEMO/IKKγ with IKKβ over TNF receptor-associated factor 2 (TRAF2), IκBα, and IKKα in co-immunoprecipitation assays using RAW 264.7 cells at concentrations ranging from 25 to 150 µM. SR 12343 inhibits TNF-α-induced NF-κB activation in a reporter assay. It reduces increased serum IL-6 levels in a mouse model of LPS-induced endotoxemia when administered at a dose of 10 mg/kg. SR 12343 (30 mg/kg) improves grip strength and reduces muscle fibrosis in the mdx mouse model of Duchenne muscular dystrophy.  

     

    Brand:
    Cayman
    SKU:31031 - 1 mg

    Available on backorder

  • SR 12343 is a mimetic of the IκB kinase β (IKKβ) NEMO/IKKγ-binding domain (NBD) that inhibits the protein-protein interaction between the IKK complex subunits NF-κB essential modulator (NEMO/IKKγ) and IKKβ.{55404} It selectively disrupts the association of NEMO/IKKγ with IKKβ over TNF receptor-associated factor 2 (TRAF2), IκBα, and IKKα in co-immunoprecipitation assays using RAW 264.7 cells at concentrations ranging from 25 to 150 µM. SR 12343 inhibits TNF-α-induced NF-κB activation in a reporter assay. It reduces increased serum IL-6 levels in a mouse model of LPS-induced endotoxemia when administered at a dose of 10 mg/kg. SR 12343 (30 mg/kg) improves grip strength and reduces muscle fibrosis in the mdx mouse model of Duchenne muscular dystrophy.  

     

    Brand:
    Cayman
    SKU:31031 - 10 mg

    Available on backorder

  • SR 12343 is a mimetic of the IκB kinase β (IKKβ) NEMO/IKKγ-binding domain (NBD) that inhibits the protein-protein interaction between the IKK complex subunits NF-κB essential modulator (NEMO/IKKγ) and IKKβ.{55404} It selectively disrupts the association of NEMO/IKKγ with IKKβ over TNF receptor-associated factor 2 (TRAF2), IκBα, and IKKα in co-immunoprecipitation assays using RAW 264.7 cells at concentrations ranging from 25 to 150 µM. SR 12343 inhibits TNF-α-induced NF-κB activation in a reporter assay. It reduces increased serum IL-6 levels in a mouse model of LPS-induced endotoxemia when administered at a dose of 10 mg/kg. SR 12343 (30 mg/kg) improves grip strength and reduces muscle fibrosis in the mdx mouse model of Duchenne muscular dystrophy.  

     

    Brand:
    Cayman
    SKU:31031 - 25 mg

    Available on backorder

  • SR 12343 is a mimetic of the IκB kinase β (IKKβ) NEMO/IKKγ-binding domain (NBD) that inhibits the protein-protein interaction between the IKK complex subunits NF-κB essential modulator (NEMO/IKKγ) and IKKβ.{55404} It selectively disrupts the association of NEMO/IKKγ with IKKβ over TNF receptor-associated factor 2 (TRAF2), IκBα, and IKKα in co-immunoprecipitation assays using RAW 264.7 cells at concentrations ranging from 25 to 150 µM. SR 12343 inhibits TNF-α-induced NF-κB activation in a reporter assay. It reduces increased serum IL-6 levels in a mouse model of LPS-induced endotoxemia when administered at a dose of 10 mg/kg. SR 12343 (30 mg/kg) improves grip strength and reduces muscle fibrosis in the mdx mouse model of Duchenne muscular dystrophy.  

     

    Brand:
    Cayman
    SKU:31031 - 5 mg

    Available on backorder

  • SR 12460 is a mimetic of the IκB kinase β (IKKβ) NEMO/IKKγ-binding domain (NBD) that inhibits the protein-protein interaction between the IKK complex subunits NF-κB essential modulator (NEMO/IKKγ) and IKKβ.{55404} It inhibits TNF-α-induced NF-κB activation in a reporter assay when used at concentrations ranging from 25 to 150 µM. It reduces LPS-induced production of IL-6 in RAW 264.7 cells. SR 12460 (30 mg/kg) improves grip strength in the mdx mouse model of Duchenne muscular dystrophy.  

     

    Brand:
    Cayman
    SKU:31066 - 1 mg

    Available on backorder

  • SR 12460 is a mimetic of the IκB kinase β (IKKβ) NEMO/IKKγ-binding domain (NBD) that inhibits the protein-protein interaction between the IKK complex subunits NF-κB essential modulator (NEMO/IKKγ) and IKKβ.{55404} It inhibits TNF-α-induced NF-κB activation in a reporter assay when used at concentrations ranging from 25 to 150 µM. It reduces LPS-induced production of IL-6 in RAW 264.7 cells. SR 12460 (30 mg/kg) improves grip strength in the mdx mouse model of Duchenne muscular dystrophy.  

     

    Brand:
    Cayman
    SKU:31066 - 10 mg

    Available on backorder

  • SR 12460 is a mimetic of the IκB kinase β (IKKβ) NEMO/IKKγ-binding domain (NBD) that inhibits the protein-protein interaction between the IKK complex subunits NF-κB essential modulator (NEMO/IKKγ) and IKKβ.{55404} It inhibits TNF-α-induced NF-κB activation in a reporter assay when used at concentrations ranging from 25 to 150 µM. It reduces LPS-induced production of IL-6 in RAW 264.7 cells. SR 12460 (30 mg/kg) improves grip strength in the mdx mouse model of Duchenne muscular dystrophy.  

     

    Brand:
    Cayman
    SKU:31066 - 25 mg

    Available on backorder

  • SR 12460 is a mimetic of the IκB kinase β (IKKβ) NEMO/IKKγ-binding domain (NBD) that inhibits the protein-protein interaction between the IKK complex subunits NF-κB essential modulator (NEMO/IKKγ) and IKKβ.{55404} It inhibits TNF-α-induced NF-κB activation in a reporter assay when used at concentrations ranging from 25 to 150 µM. It reduces LPS-induced production of IL-6 in RAW 264.7 cells. SR 12460 (30 mg/kg) improves grip strength in the mdx mouse model of Duchenne muscular dystrophy.  

     

    Brand:
    Cayman
    SKU:31066 - 5 mg

    Available on backorder

  • SR 144528 is a cannabinoid (CB) receptor 2 inverse agonist with Ki values ranging from 0.3 to 5.6 nM.{7912} It is selective for CB2 over CB1 receptors, where it has Ki values ranging from 305 to >10,000 nM. SR 144528 blocks the inhibitory effects of CP 55,940 on forskolin-induced adenylyl cyclase activity in CHO cells expressing hCB2 (IC50 = 10 nM) but not in cells expressing hCB1 (IC50 = >10 µM).{17199} SR 144528 has been used to investigate the contribution of the CB2 receptor in the control of pain initiation as well as suppression of inflammation and immune activation.{7921,16339,14732,16336}  

     

    Brand:
    Cayman
    SKU:9000491 - 10 mg

    Available on backorder

  • SR 144528 is a cannabinoid (CB) receptor 2 inverse agonist with Ki values ranging from 0.3 to 5.6 nM.{7912} It is selective for CB2 over CB1 receptors, where it has Ki values ranging from 305 to >10,000 nM. SR 144528 blocks the inhibitory effects of CP 55,940 on forskolin-induced adenylyl cyclase activity in CHO cells expressing hCB2 (IC50 = 10 nM) but not in cells expressing hCB1 (IC50 = >10 µM).{17199} SR 144528 has been used to investigate the contribution of the CB2 receptor in the control of pain initiation as well as suppression of inflammation and immune activation.{7921,16339,14732,16336}  

     

    Brand:
    Cayman
    SKU:9000491 - 25 mg

    Available on backorder

  • SR 144528 is a cannabinoid (CB) receptor 2 inverse agonist with Ki values ranging from 0.3 to 5.6 nM.{7912} It is selective for CB2 over CB1 receptors, where it has Ki values ranging from 305 to >10,000 nM. SR 144528 blocks the inhibitory effects of CP 55,940 on forskolin-induced adenylyl cyclase activity in CHO cells expressing hCB2 (IC50 = 10 nM) but not in cells expressing hCB1 (IC50 = >10 µM).{17199} SR 144528 has been used to investigate the contribution of the CB2 receptor in the control of pain initiation as well as suppression of inflammation and immune activation.{7921,16339,14732,16336}  

     

    Brand:
    Cayman
    SKU:9000491 - 5 mg

    Available on backorder

  • SR 144528 is a cannabinoid (CB) receptor 2 inverse agonist with Ki values ranging from 0.3 to 5.6 nM.{7912} It is selective for CB2 over CB1 receptors, where it has Ki values ranging from 305 to >10,000 nM. SR 144528 blocks the inhibitory effects of CP 55,940 on forskolin-induced adenylyl cyclase activity in CHO cells expressing hCB2 (IC50 = 10 nM) but not in cells expressing hCB1 (IC50 = >10 µM).{17199} SR 144528 has been used to investigate the contribution of the CB2 receptor in the control of pain initiation as well as suppression of inflammation and immune activation.{7921,16339,14732,16336}  

     

    Brand:
    Cayman
    SKU:9000491 - 50 mg

    Available on backorder

  • Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels in the central and peripheral nervous system. SR 16584 is an antagonist of the α3β4 nAChR subtype (IC50 = 10.2 μM).{18814} It shows selective binding of the α3β4 subtype compared to the α4β2 and α7 subtypes (Ki values of 0.508, >100, and >100 μM, respectively), indicating that it should be a useful tool for receptor subtype studies.{18814}  

     

    Brand:
    Cayman
    SKU:10683 - 1 mg

    Available on backorder

  • Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels in the central and peripheral nervous system. SR 16584 is an antagonist of the α3β4 nAChR subtype (IC50 = 10.2 μM).{18814} It shows selective binding of the α3β4 subtype compared to the α4β2 and α7 subtypes (Ki values of 0.508, >100, and >100 μM, respectively), indicating that it should be a useful tool for receptor subtype studies.{18814}  

     

    Brand:
    Cayman
    SKU:10683 - 10 mg

    Available on backorder

  • Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels in the central and peripheral nervous system. SR 16584 is an antagonist of the α3β4 nAChR subtype (IC50 = 10.2 μM).{18814} It shows selective binding of the α3β4 subtype compared to the α4β2 and α7 subtypes (Ki values of 0.508, >100, and >100 μM, respectively), indicating that it should be a useful tool for receptor subtype studies.{18814}  

     

    Brand:
    Cayman
    SKU:10683 - 5 mg

    Available on backorder

  • Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels in the central and peripheral nervous system. SR 16584 is an antagonist of the α3β4 nAChR subtype (IC50 = 10.2 μM).{18814} It shows selective binding of the α3β4 subtype compared to the α4β2 and α7 subtypes (Ki values of 0.508, >100, and >100 μM, respectively), indicating that it should be a useful tool for receptor subtype studies.{18814}  

     

    Brand:
    Cayman
    SKU:10683 - 50 mg

    Available on backorder

  • Apart from direct peroxisome proliferator-activated receptor γ (PPARγ) agonism, several PPARγ ligands have recently been shown to exert anti-diabetic effects through a second, distinct biochemical function: blocking the obesity-linked phosphorylation of PPARγ by cyclin-dependent kinase 5 (Cdk5) at serine 273.{25001} This effect requires binding to the PPARγ ligand binding domain, which causes a conformational change that interferes with the ability of Cdk5 to phosphorylate serine 273. SR 1664 is a small molecule that blocks phosphorylation of peroxisome proliferator-activated receptor γ (PPARγ) by cyclin-dependent kinase 5 with an IC50 value of 80 nM (Ki = 28.7 nM) without exhibiting agonist activity at the PPARγ receptor.{25002} It demonstrates potent, dose-dependent anti-diabetic effects in obese mice without inducing fluid retention and weight gain or inhibiting bone formation.{25002}  

     

    Brand:
    Cayman
    SKU:11086 - 1 mg

    Available on backorder

  • Apart from direct peroxisome proliferator-activated receptor γ (PPARγ) agonism, several PPARγ ligands have recently been shown to exert anti-diabetic effects through a second, distinct biochemical function: blocking the obesity-linked phosphorylation of PPARγ by cyclin-dependent kinase 5 (Cdk5) at serine 273.{25001} This effect requires binding to the PPARγ ligand binding domain, which causes a conformational change that interferes with the ability of Cdk5 to phosphorylate serine 273. SR 1664 is a small molecule that blocks phosphorylation of peroxisome proliferator-activated receptor γ (PPARγ) by cyclin-dependent kinase 5 with an IC50 value of 80 nM (Ki = 28.7 nM) without exhibiting agonist activity at the PPARγ receptor.{25002} It demonstrates potent, dose-dependent anti-diabetic effects in obese mice without inducing fluid retention and weight gain or inhibiting bone formation.{25002}  

     

    Brand:
    Cayman
    SKU:11086 - 10 mg

    Available on backorder

  • Apart from direct peroxisome proliferator-activated receptor γ (PPARγ) agonism, several PPARγ ligands have recently been shown to exert anti-diabetic effects through a second, distinct biochemical function: blocking the obesity-linked phosphorylation of PPARγ by cyclin-dependent kinase 5 (Cdk5) at serine 273.{25001} This effect requires binding to the PPARγ ligand binding domain, which causes a conformational change that interferes with the ability of Cdk5 to phosphorylate serine 273. SR 1664 is a small molecule that blocks phosphorylation of peroxisome proliferator-activated receptor γ (PPARγ) by cyclin-dependent kinase 5 with an IC50 value of 80 nM (Ki = 28.7 nM) without exhibiting agonist activity at the PPARγ receptor.{25002} It demonstrates potent, dose-dependent anti-diabetic effects in obese mice without inducing fluid retention and weight gain or inhibiting bone formation.{25002}  

     

    Brand:
    Cayman
    SKU:11086 - 25 mg

    Available on backorder

  • Apart from direct peroxisome proliferator-activated receptor γ (PPARγ) agonism, several PPARγ ligands have recently been shown to exert anti-diabetic effects through a second, distinct biochemical function: blocking the obesity-linked phosphorylation of PPARγ by cyclin-dependent kinase 5 (Cdk5) at serine 273.{25001} This effect requires binding to the PPARγ ligand binding domain, which causes a conformational change that interferes with the ability of Cdk5 to phosphorylate serine 273. SR 1664 is a small molecule that blocks phosphorylation of peroxisome proliferator-activated receptor γ (PPARγ) by cyclin-dependent kinase 5 with an IC50 value of 80 nM (Ki = 28.7 nM) without exhibiting agonist activity at the PPARγ receptor.{25002} It demonstrates potent, dose-dependent anti-diabetic effects in obese mice without inducing fluid retention and weight gain or inhibiting bone formation.{25002}  

     

    Brand:
    Cayman
    SKU:11086 - 5 mg

    Available on backorder

  • SR 16832 is a dual-site covalent antagonist of peroxisome proliferator-activated receptor γ (PPARγ).{42885} It inhibits MRL20-induced allosteric activation of PPARγ in a reporter assay using HEK293T cells when used at a concentration of 5 μM. SR 16832 also reduces basal activity of PPARγ and inhibits binding of docosahexaenoic acid (DHA; Item No. 90310) to PPARγ in a time-resolved FRET (TR-FRET) assay.  

     

    Brand:
    Cayman
    SKU:27632 - 1 mg

    Available on backorder

  • SR 16832 is a dual-site covalent antagonist of peroxisome proliferator-activated receptor γ (PPARγ).{42885} It inhibits MRL20-induced allosteric activation of PPARγ in a reporter assay using HEK293T cells when used at a concentration of 5 μM. SR 16832 also reduces basal activity of PPARγ and inhibits binding of docosahexaenoic acid (DHA; Item No. 90310) to PPARγ in a time-resolved FRET (TR-FRET) assay.  

     

    Brand:
    Cayman
    SKU:27632 - 10 mg

    Available on backorder

  • SR 16832 is a dual-site covalent antagonist of peroxisome proliferator-activated receptor γ (PPARγ).{42885} It inhibits MRL20-induced allosteric activation of PPARγ in a reporter assay using HEK293T cells when used at a concentration of 5 μM. SR 16832 also reduces basal activity of PPARγ and inhibits binding of docosahexaenoic acid (DHA; Item No. 90310) to PPARγ in a time-resolved FRET (TR-FRET) assay.  

     

    Brand:
    Cayman
    SKU:27632 - 25 mg

    Available on backorder

  • SR 16832 is a dual-site covalent antagonist of peroxisome proliferator-activated receptor γ (PPARγ).{42885} It inhibits MRL20-induced allosteric activation of PPARγ in a reporter assay using HEK293T cells when used at a concentration of 5 μM. SR 16832 also reduces basal activity of PPARγ and inhibits binding of docosahexaenoic acid (DHA; Item No. 90310) to PPARγ in a time-resolved FRET (TR-FRET) assay.  

     

    Brand:
    Cayman
    SKU:27632 - 5 mg

    Available on backorder

  • SR 17018 is an orally bioavailable and brain-penetrant agonist of μ-opioid receptors.{40627} It is functionally selective for G protein-coupled receptor signaling (EC50 = 97 nM for GTPγS binding in CHO cells expressing μ-opioid receptors) over β-arrestin 2 recruitment (EC50 = >10,000 nM) at the μ-opioid receptor. SR 17018 increases latency to withdraw in the hot plate and warm water tail-flick assay (ED50s = 6.9 and 7.7 mg/kg, respectively) without inducing respiratory depression in mice when administered at doses up to 48 mg/kg. SR 17018 was designed for this biased agonism at the μ-opioid receptor to potentially widen the therapeutic window and reduce adverse effects of μ-opioid receptors, such as respiratory depression.  

     

    Brand:
    Cayman
    SKU:24480 - 1 mg

    Available on backorder

  • SR 17018 is an orally bioavailable and brain-penetrant agonist of μ-opioid receptors.{40627} It is functionally selective for G protein-coupled receptor signaling (EC50 = 97 nM for GTPγS binding in CHO cells expressing μ-opioid receptors) over β-arrestin 2 recruitment (EC50 = >10,000 nM) at the μ-opioid receptor. SR 17018 increases latency to withdraw in the hot plate and warm water tail-flick assay (ED50s = 6.9 and 7.7 mg/kg, respectively) without inducing respiratory depression in mice when administered at doses up to 48 mg/kg. SR 17018 was designed for this biased agonism at the μ-opioid receptor to potentially widen the therapeutic window and reduce adverse effects of μ-opioid receptors, such as respiratory depression.  

     

    Brand:
    Cayman
    SKU:24480 - 10 mg

    Available on backorder

  • SR 17018 is an orally bioavailable and brain-penetrant agonist of μ-opioid receptors.{40627} It is functionally selective for G protein-coupled receptor signaling (EC50 = 97 nM for GTPγS binding in CHO cells expressing μ-opioid receptors) over β-arrestin 2 recruitment (EC50 = >10,000 nM) at the μ-opioid receptor. SR 17018 increases latency to withdraw in the hot plate and warm water tail-flick assay (ED50s = 6.9 and 7.7 mg/kg, respectively) without inducing respiratory depression in mice when administered at doses up to 48 mg/kg. SR 17018 was designed for this biased agonism at the μ-opioid receptor to potentially widen the therapeutic window and reduce adverse effects of μ-opioid receptors, such as respiratory depression.  

     

    Brand:
    Cayman
    SKU:24480 - 25 mg

    Available on backorder

  • SR 17018 is an orally bioavailable and brain-penetrant agonist of μ-opioid receptors.{40627} It is functionally selective for G protein-coupled receptor signaling (EC50 = 97 nM for GTPγS binding in CHO cells expressing μ-opioid receptors) over β-arrestin 2 recruitment (EC50 = >10,000 nM) at the μ-opioid receptor. SR 17018 increases latency to withdraw in the hot plate and warm water tail-flick assay (ED50s = 6.9 and 7.7 mg/kg, respectively) without inducing respiratory depression in mice when administered at doses up to 48 mg/kg. SR 17018 was designed for this biased agonism at the μ-opioid receptor to potentially widen the therapeutic window and reduce adverse effects of μ-opioid receptors, such as respiratory depression.  

     

    Brand:
    Cayman
    SKU:24480 - 5 mg

    Available on backorder

  • Peroxisome proliferator-activated receptor γ (PPARγ) is activated by the anti-diabetes drugs known as thiazolidinediones, including rosiglitazone (Item No. 71740) and pioglitazone (Item No. 71745).{8461} Phosphorylation of PPARγ by cyclin-dependent kinase 5 (Cdk5) causes dysregulation of genes whose expression is altered in obesity, including adiponectin.{18956} SR 1824 is a non-agonist PPARγ ligand (Ki = 10 nM) which blocks Cdk5-mediated phosphorylation.{20015} It does not inhibit activation of PPARγ by rosiglitazone (Item No. 71740).{20015}  

     

    Brand:
    Cayman
    SKU:11087 - 1 mg

    Available on backorder

  • Peroxisome proliferator-activated receptor γ (PPARγ) is activated by the anti-diabetes drugs known as thiazolidinediones, including rosiglitazone (Item No. 71740) and pioglitazone (Item No. 71745).{8461} Phosphorylation of PPARγ by cyclin-dependent kinase 5 (Cdk5) causes dysregulation of genes whose expression is altered in obesity, including adiponectin.{18956} SR 1824 is a non-agonist PPARγ ligand (Ki = 10 nM) which blocks Cdk5-mediated phosphorylation.{20015} It does not inhibit activation of PPARγ by rosiglitazone (Item No. 71740).{20015}  

     

    Brand:
    Cayman
    SKU:11087 - 10 mg

    Available on backorder

  • Peroxisome proliferator-activated receptor γ (PPARγ) is activated by the anti-diabetes drugs known as thiazolidinediones, including rosiglitazone (Item No. 71740) and pioglitazone (Item No. 71745).{8461} Phosphorylation of PPARγ by cyclin-dependent kinase 5 (Cdk5) causes dysregulation of genes whose expression is altered in obesity, including adiponectin.{18956} SR 1824 is a non-agonist PPARγ ligand (Ki = 10 nM) which blocks Cdk5-mediated phosphorylation.{20015} It does not inhibit activation of PPARγ by rosiglitazone (Item No. 71740).{20015}  

     

    Brand:
    Cayman
    SKU:11087 - 25 mg

    Available on backorder

  • Peroxisome proliferator-activated receptor γ (PPARγ) is activated by the anti-diabetes drugs known as thiazolidinediones, including rosiglitazone (Item No. 71740) and pioglitazone (Item No. 71745).{8461} Phosphorylation of PPARγ by cyclin-dependent kinase 5 (Cdk5) causes dysregulation of genes whose expression is altered in obesity, including adiponectin.{18956} SR 1824 is a non-agonist PPARγ ligand (Ki = 10 nM) which blocks Cdk5-mediated phosphorylation.{20015} It does not inhibit activation of PPARγ by rosiglitazone (Item No. 71740).{20015}  

     

    Brand:
    Cayman
    SKU:11087 - 5 mg

    Available on backorder

  • SR 18292 is an inhibitor of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), a coactivator of transcription factors for genes involved in gluconeogenesis.{37125} SR 18292 (20 µM) increases acetylation of PGC-1α and, subsequently, decreases mRNA expression of phosphoenolpyruvate carboxykinase 1 (PEPCK1/Pck1) and the glucose-6-phosphatase catalytic subunit (G6Pc) in primary hepatocytes following stimulation with glucagon. In a dietary model of type II diabetes mellitus in mice, SR 18292 (45 mg/kg, i.p., for four days) reduces fasting blood glucose levels and the expression of liver Pck1. It also enhances glucose tolerance and insulin sensitivity in two mouse models of obesity.  

     

    Brand:
    Cayman
    SKU:22084 -

    Out of stock

  • SR 18292 is an inhibitor of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), a coactivator of transcription factors for genes involved in gluconeogenesis.{37125} SR 18292 (20 µM) increases acetylation of PGC-1α and, subsequently, decreases mRNA expression of phosphoenolpyruvate carboxykinase 1 (PEPCK1/Pck1) and the glucose-6-phosphatase catalytic subunit (G6Pc) in primary hepatocytes following stimulation with glucagon. In a dietary model of type II diabetes mellitus in mice, SR 18292 (45 mg/kg, i.p., for four days) reduces fasting blood glucose levels and the expression of liver Pck1. It also enhances glucose tolerance and insulin sensitivity in two mouse models of obesity.  

     

    Brand:
    Cayman
    SKU:22084 -

    Out of stock

  • SR 18292 is an inhibitor of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), a coactivator of transcription factors for genes involved in gluconeogenesis.{37125} SR 18292 (20 µM) increases acetylation of PGC-1α and, subsequently, decreases mRNA expression of phosphoenolpyruvate carboxykinase 1 (PEPCK1/Pck1) and the glucose-6-phosphatase catalytic subunit (G6Pc) in primary hepatocytes following stimulation with glucagon. In a dietary model of type II diabetes mellitus in mice, SR 18292 (45 mg/kg, i.p., for four days) reduces fasting blood glucose levels and the expression of liver Pck1. It also enhances glucose tolerance and insulin sensitivity in two mouse models of obesity.  

     

    Brand:
    Cayman
    SKU:22084 -

    Out of stock

  • SR 18292 is an inhibitor of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), a coactivator of transcription factors for genes involved in gluconeogenesis.{37125} SR 18292 (20 µM) increases acetylation of PGC-1α and, subsequently, decreases mRNA expression of phosphoenolpyruvate carboxykinase 1 (PEPCK1/Pck1) and the glucose-6-phosphatase catalytic subunit (G6Pc) in primary hepatocytes following stimulation with glucagon. In a dietary model of type II diabetes mellitus in mice, SR 18292 (45 mg/kg, i.p., for four days) reduces fasting blood glucose levels and the expression of liver Pck1. It also enhances glucose tolerance and insulin sensitivity in two mouse models of obesity.  

     

    Brand:
    Cayman
    SKU:22084 -

    Out of stock

  • SR 1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR).{35980} It is an inverse agonist of RORγ (IC50 = ~100 nM in a cell-based reporter assay) and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPARγ; IC50 = 209 nM) but does not activate it. SR 1903 (10 μM) inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1) in RAW 264.7 cells. It also inhibits LPS-induced expression of the LXR target genes IL-6 and IL-33 and increases expression of ABCG1, FASN, and SCD-1 in RAW 264.7 cells. SR 1903 (20 mg/kg twice per day) reduces severity score in a mouse model of collagen-induced arthritis. It reduces blood glucose levels in a glucose tolerance test, serum levels of total cholesterol and LDL, body weight, and fat mass in a mouse model of high-fat diet-induced obesity.  

     

    Brand:
    Cayman
    SKU:28253 - 1 mg

    Available on backorder

  • SR 1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR).{35980} It is an inverse agonist of RORγ (IC50 = ~100 nM in a cell-based reporter assay) and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPARγ; IC50 = 209 nM) but does not activate it. SR 1903 (10 μM) inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1) in RAW 264.7 cells. It also inhibits LPS-induced expression of the LXR target genes IL-6 and IL-33 and increases expression of ABCG1, FASN, and SCD-1 in RAW 264.7 cells. SR 1903 (20 mg/kg twice per day) reduces severity score in a mouse model of collagen-induced arthritis. It reduces blood glucose levels in a glucose tolerance test, serum levels of total cholesterol and LDL, body weight, and fat mass in a mouse model of high-fat diet-induced obesity.  

     

    Brand:
    Cayman
    SKU:28253 - 10 mg

    Available on backorder

  • SR 1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR).{35980} It is an inverse agonist of RORγ (IC50 = ~100 nM in a cell-based reporter assay) and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPARγ; IC50 = 209 nM) but does not activate it. SR 1903 (10 μM) inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1) in RAW 264.7 cells. It also inhibits LPS-induced expression of the LXR target genes IL-6 and IL-33 and increases expression of ABCG1, FASN, and SCD-1 in RAW 264.7 cells. SR 1903 (20 mg/kg twice per day) reduces severity score in a mouse model of collagen-induced arthritis. It reduces blood glucose levels in a glucose tolerance test, serum levels of total cholesterol and LDL, body weight, and fat mass in a mouse model of high-fat diet-induced obesity.  

     

    Brand:
    Cayman
    SKU:28253 - 5 mg

    Available on backorder

  • SR 202 is an antagonist of peroxisome proliferator-activated receptor γ (PPARγ) transcriptional activity induced by troglitazone (Item No. 71750; IC50 = 140 µM) but not of basal PPARγ activity.{10768} It is selective for PPARγ, not affecting basal or agonist-induced transcriptional activity of PPARα, PPARβ, or the farnesoid X receptor (FXR). It inhibits PPARγ-dependent differentiation of preadipocyte 3T3-L1 cells in a dose-dependent manner. SR 202 (400 mg/kg) decreases the amount of weight gained and white adipose tissue mass accumulated by mice fed a standard or high-fat diet for ten weeks and is associated with lower PPARγ mRNA levels. It protects against high-fat diet-induced insulin resistance in wild-type mice and improves insulin sensitivity in ob/ob mice.  

     

    Brand:
    Cayman
    SKU:21846 -

    Out of stock

  • SR 202 is an antagonist of peroxisome proliferator-activated receptor γ (PPARγ) transcriptional activity induced by troglitazone (Item No. 71750; IC50 = 140 µM) but not of basal PPARγ activity.{10768} It is selective for PPARγ, not affecting basal or agonist-induced transcriptional activity of PPARα, PPARβ, or the farnesoid X receptor (FXR). It inhibits PPARγ-dependent differentiation of preadipocyte 3T3-L1 cells in a dose-dependent manner. SR 202 (400 mg/kg) decreases the amount of weight gained and white adipose tissue mass accumulated by mice fed a standard or high-fat diet for ten weeks and is associated with lower PPARγ mRNA levels. It protects against high-fat diet-induced insulin resistance in wild-type mice and improves insulin sensitivity in ob/ob mice.  

     

    Brand:
    Cayman
    SKU:21846 -

    Out of stock

  • Retinoic acid receptor-related nuclear receptor γ (RORγ) plays a central role in T cell differentiation, particularly in the differentiation of pro-inflammatory TH17 cells, which are implicated in autoimmune diseases like multiple sclerosis and rheumatoid arthritis.{19869,19493} SR 2211 selectively binds RORγ (Ki = 105 nM), acting as an inverse agonist of constitutive in vitro RORγ activity (IC50 = 320 nM).{21866} It has minimal effects on RORα, LXRα, and FXR activities. SR 2211 significantly inhibits gene expression of IL-17 and IL-23 receptor in activated EL-4 mouse T lymphocytes when given at 5 μM.{21866}  

     

    Brand:
    Cayman
    SKU:11972 - 1 mg

    Available on backorder

  • Retinoic acid receptor-related nuclear receptor γ (RORγ) plays a central role in T cell differentiation, particularly in the differentiation of pro-inflammatory TH17 cells, which are implicated in autoimmune diseases like multiple sclerosis and rheumatoid arthritis.{19869,19493} SR 2211 selectively binds RORγ (Ki = 105 nM), acting as an inverse agonist of constitutive in vitro RORγ activity (IC50 = 320 nM).{21866} It has minimal effects on RORα, LXRα, and FXR activities. SR 2211 significantly inhibits gene expression of IL-17 and IL-23 receptor in activated EL-4 mouse T lymphocytes when given at 5 μM.{21866}  

     

    Brand:
    Cayman
    SKU:11972 - 10 mg

    Available on backorder

  • Retinoic acid receptor-related nuclear receptor γ (RORγ) plays a central role in T cell differentiation, particularly in the differentiation of pro-inflammatory TH17 cells, which are implicated in autoimmune diseases like multiple sclerosis and rheumatoid arthritis.{19869,19493} SR 2211 selectively binds RORγ (Ki = 105 nM), acting as an inverse agonist of constitutive in vitro RORγ activity (IC50 = 320 nM).{21866} It has minimal effects on RORα, LXRα, and FXR activities. SR 2211 significantly inhibits gene expression of IL-17 and IL-23 receptor in activated EL-4 mouse T lymphocytes when given at 5 μM.{21866}  

     

    Brand:
    Cayman
    SKU:11972 - 5 mg

    Available on backorder

  • SR 2595 is an inverse agonist of PPARγ (IC50 = 30 nM) that represses both transactivation in a promoter:reporter assay and expression of the adipogenic marker fatty acid-binding protein 4 in differentiating murine preadipocytes.{29288} Repression of PPARγ with SR 2595 promotes osteogenesis, as measured by calcium phosphatase deposition, in cultured human mesenchymal stem cells (MSCs).{29288} SR 2595 also increases expression of bone morphogenetic proteins BMP2 and BMP6 in MSCs.{29288}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • SR 2595 is an inverse agonist of PPARγ (IC50 = 30 nM) that represses both transactivation in a promoter:reporter assay and expression of the adipogenic marker fatty acid-binding protein 4 in differentiating murine preadipocytes.{29288} Repression of PPARγ with SR 2595 promotes osteogenesis, as measured by calcium phosphatase deposition, in cultured human mesenchymal stem cells (MSCs).{29288} SR 2595 also increases expression of bone morphogenetic proteins BMP2 and BMP6 in MSCs.{29288}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • SR 2595 is an inverse agonist of PPARγ (IC50 = 30 nM) that represses both transactivation in a promoter:reporter assay and expression of the adipogenic marker fatty acid-binding protein 4 in differentiating murine preadipocytes.{29288} Repression of PPARγ with SR 2595 promotes osteogenesis, as measured by calcium phosphatase deposition, in cultured human mesenchymal stem cells (MSCs).{29288} SR 2595 also increases expression of bone morphogenetic proteins BMP2 and BMP6 in MSCs.{29288}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • SR 27897 is a nonpeptide cholecystokinin (CCK) receptor antagonist.{42981} It selectively binds to CCK1 receptors in rat pancreatic membranes (IC50 = 0.58 nM) over CCK2 receptors in guinea pig cortical membranes and gastrin receptors in guinea pig gastric gland suspensions (IC50s = 489 and 2,883 nM, respectively). SR 27897 inhibits amylase secretion induced by CCK in isolated rat pancreatic acini (pA2 = 7.50) and CCK-induced guinea pig gallbladder contractions ex vivo (pA2 = 9.57). It completely reverses CCK-induced amylase secretion in rats when administered at a dose of 1 mg/kg. SR 27897 also inhibits CCK-induced gastric and gallbladder emptying in mice (ED50s = 3 and 72 μg/kg, respectively). SR 27897 inhibits gallbladder emptying in a mouse model of egg yolk-stimulated endogenous CCK release (ED50 = 27 μg/kg).  

     

    Brand:
    Cayman
    SKU:28511 - 10 mg

    Available on backorder

  • SR 27897 is a nonpeptide cholecystokinin (CCK) receptor antagonist.{42981} It selectively binds to CCK1 receptors in rat pancreatic membranes (IC50 = 0.58 nM) over CCK2 receptors in guinea pig cortical membranes and gastrin receptors in guinea pig gastric gland suspensions (IC50s = 489 and 2,883 nM, respectively). SR 27897 inhibits amylase secretion induced by CCK in isolated rat pancreatic acini (pA2 = 7.50) and CCK-induced guinea pig gallbladder contractions ex vivo (pA2 = 9.57). It completely reverses CCK-induced amylase secretion in rats when administered at a dose of 1 mg/kg. SR 27897 also inhibits CCK-induced gastric and gallbladder emptying in mice (ED50s = 3 and 72 μg/kg, respectively). SR 27897 inhibits gallbladder emptying in a mouse model of egg yolk-stimulated endogenous CCK release (ED50 = 27 μg/kg).  

     

    Brand:
    Cayman
    SKU:28511 - 25 mg

    Available on backorder

  • SR 27897 is a nonpeptide cholecystokinin (CCK) receptor antagonist.{42981} It selectively binds to CCK1 receptors in rat pancreatic membranes (IC50 = 0.58 nM) over CCK2 receptors in guinea pig cortical membranes and gastrin receptors in guinea pig gastric gland suspensions (IC50s = 489 and 2,883 nM, respectively). SR 27897 inhibits amylase secretion induced by CCK in isolated rat pancreatic acini (pA2 = 7.50) and CCK-induced guinea pig gallbladder contractions ex vivo (pA2 = 9.57). It completely reverses CCK-induced amylase secretion in rats when administered at a dose of 1 mg/kg. SR 27897 also inhibits CCK-induced gastric and gallbladder emptying in mice (ED50s = 3 and 72 μg/kg, respectively). SR 27897 inhibits gallbladder emptying in a mouse model of egg yolk-stimulated endogenous CCK release (ED50 = 27 μg/kg).  

     

    Brand:
    Cayman
    SKU:28511 - 5 mg

    Available on backorder

  • SR 27897 is a nonpeptide cholecystokinin (CCK) receptor antagonist.{42981} It selectively binds to CCK1 receptors in rat pancreatic membranes (IC50 = 0.58 nM) over CCK2 receptors in guinea pig cortical membranes and gastrin receptors in guinea pig gastric gland suspensions (IC50s = 489 and 2,883 nM, respectively). SR 27897 inhibits amylase secretion induced by CCK in isolated rat pancreatic acini (pA2 = 7.50) and CCK-induced guinea pig gallbladder contractions ex vivo (pA2 = 9.57). It completely reverses CCK-induced amylase secretion in rats when administered at a dose of 1 mg/kg. SR 27897 also inhibits CCK-induced gastric and gallbladder emptying in mice (ED50s = 3 and 72 μg/kg, respectively). SR 27897 inhibits gallbladder emptying in a mouse model of egg yolk-stimulated endogenous CCK release (ED50 = 27 μg/kg).  

     

    Brand:
    Cayman
    SKU:28511 - 50 mg

    Available on backorder

  • SR 3029 is an inhibitor of casein kinase 1δ (CK1δ) and CK1ε (IC50s = 44 and 260 nM, respectively).{47522} It is selective for CK1δ and CK1ε over 438 kinases in a panel but also inhibits MYLK4, FLT3, Cdk4/cyclin D1, and MARK2 by greater than 90% at 10 µM. SR 3029 inhibits Cdk4/cyclin D1, Cdk4/cyclin D3, Cdk6/cyclin D1, Cdk6/cyclin D3, and FLT3 with IC50 values of 576, 368, 428, 427, and 3,000 nM, respectively. It inhibits proliferation of A375 human melanoma cells in vitro (EC50 = 86 nM). SR 3029 (20 mg/kg per day) reduces tumor growth and increases lifespan in MDA-MB-231 and MDA-MB-468 mouse xenograft models.{47523} It reduces the expression of the Wnt/β-catenin target CCND1 and decreases protein levels of nuclear β-catenin and cyclin D1 in mouse tumor tissue.  

     

    Brand:
    Cayman
    SKU:27048 - 10 mg

    Available on backorder

  • SR 3029 is an inhibitor of casein kinase 1δ (CK1δ) and CK1ε (IC50s = 44 and 260 nM, respectively).{47522} It is selective for CK1δ and CK1ε over 438 kinases in a panel but also inhibits MYLK4, FLT3, Cdk4/cyclin D1, and MARK2 by greater than 90% at 10 µM. SR 3029 inhibits Cdk4/cyclin D1, Cdk4/cyclin D3, Cdk6/cyclin D1, Cdk6/cyclin D3, and FLT3 with IC50 values of 576, 368, 428, 427, and 3,000 nM, respectively. It inhibits proliferation of A375 human melanoma cells in vitro (EC50 = 86 nM). SR 3029 (20 mg/kg per day) reduces tumor growth and increases lifespan in MDA-MB-231 and MDA-MB-468 mouse xenograft models.{47523} It reduces the expression of the Wnt/β-catenin target CCND1 and decreases protein levels of nuclear β-catenin and cyclin D1 in mouse tumor tissue.  

     

    Brand:
    Cayman
    SKU:27048 - 25 mg

    Available on backorder

  • SR 3029 is an inhibitor of casein kinase 1δ (CK1δ) and CK1ε (IC50s = 44 and 260 nM, respectively).{47522} It is selective for CK1δ and CK1ε over 438 kinases in a panel but also inhibits MYLK4, FLT3, Cdk4/cyclin D1, and MARK2 by greater than 90% at 10 µM. SR 3029 inhibits Cdk4/cyclin D1, Cdk4/cyclin D3, Cdk6/cyclin D1, Cdk6/cyclin D3, and FLT3 with IC50 values of 576, 368, 428, 427, and 3,000 nM, respectively. It inhibits proliferation of A375 human melanoma cells in vitro (EC50 = 86 nM). SR 3029 (20 mg/kg per day) reduces tumor growth and increases lifespan in MDA-MB-231 and MDA-MB-468 mouse xenograft models.{47523} It reduces the expression of the Wnt/β-catenin target CCND1 and decreases protein levels of nuclear β-catenin and cyclin D1 in mouse tumor tissue.  

     

    Brand:
    Cayman
    SKU:27048 - 5 mg

    Available on backorder

  • The retinoic acid receptor-related receptors (RORs) are orphan nuclear receptors with diverse putative roles.{19493,19955,19869} SR 3335 is a selective inverse agonist of RORα, competitively inhibiting the binding of 25-hydroxycholesterol to the ligand binding domain (Ki = 220 nM) and inhibiting constitutive transactivation activity (IC50 = 480 nM).{21470} It is without effect on RORβ, RORγ, farnesoid X receptor, or liver X receptor α. SR 3335 evokes RORα-dependent effects both in vitro and in vivo, altering gene expression as well as gluconeogenesis.{21470}  

     

    Brand:
    Cayman
    SKU:12072 - 1 mg

    Available on backorder

  • The retinoic acid receptor-related receptors (RORs) are orphan nuclear receptors with diverse putative roles.{19493,19955,19869} SR 3335 is a selective inverse agonist of RORα, competitively inhibiting the binding of 25-hydroxycholesterol to the ligand binding domain (Ki = 220 nM) and inhibiting constitutive transactivation activity (IC50 = 480 nM).{21470} It is without effect on RORβ, RORγ, farnesoid X receptor, or liver X receptor α. SR 3335 evokes RORα-dependent effects both in vitro and in vivo, altering gene expression as well as gluconeogenesis.{21470}  

     

    Brand:
    Cayman
    SKU:12072 - 10 mg

    Available on backorder

  • The retinoic acid receptor-related receptors (RORs) are orphan nuclear receptors with diverse putative roles.{19493,19955,19869} SR 3335 is a selective inverse agonist of RORα, competitively inhibiting the binding of 25-hydroxycholesterol to the ligand binding domain (Ki = 220 nM) and inhibiting constitutive transactivation activity (IC50 = 480 nM).{21470} It is without effect on RORβ, RORγ, farnesoid X receptor, or liver X receptor α. SR 3335 evokes RORα-dependent effects both in vitro and in vivo, altering gene expression as well as gluconeogenesis.{21470}  

     

    Brand:
    Cayman
    SKU:12072 - 25 mg

    Available on backorder

  • The retinoic acid receptor-related receptors (RORs) are orphan nuclear receptors with diverse putative roles.{19493,19955,19869} SR 3335 is a selective inverse agonist of RORα, competitively inhibiting the binding of 25-hydroxycholesterol to the ligand binding domain (Ki = 220 nM) and inhibiting constitutive transactivation activity (IC50 = 480 nM).{21470} It is without effect on RORβ, RORγ, farnesoid X receptor, or liver X receptor α. SR 3335 evokes RORα-dependent effects both in vitro and in vivo, altering gene expression as well as gluconeogenesis.{21470}  

     

    Brand:
    Cayman
    SKU:12072 - 5 mg

    Available on backorder

  • SR 3576 is a JNK3 inhibitor (IC50 = 7 nM).{57073} It is selective for JNK3 over JNK1 and p38 MAP kinase (IC50s = 0.17 and >20 µM, respectively). It inhibits c-Jun phosphorylation in INS-1 cells (IC50 = 1.3 µM).  

     

    Brand:
    Cayman
    SKU:20215 -

    Available on backorder

  • SR 3576 is a JNK3 inhibitor (IC50 = 7 nM).{57073} It is selective for JNK3 over JNK1 and p38 MAP kinase (IC50s = 0.17 and >20 µM, respectively). It inhibits c-Jun phosphorylation in INS-1 cells (IC50 = 1.3 µM).  

     

    Brand:
    Cayman
    SKU:20215 -

    Available on backorder

  • SR 3677 is a potent, ATP-competitive inhibitor of Rho-associated kinases (ROCKs) that shows greater potency against ROCK-II than ROCK-I in enzyme and cell-based assays (IC50 values are 3 and 56 nM, respectively).{27385} At 3 µM, SR 3677 inhibits only 5 (Akt3, Clk1, Clk2, Clk4, Lats2) out of 353 kinases with greater than 50% inhibition.{27385} SR 3677 is efficacious at inhibiting myosin light chain phosphorylation and increasing aqueous humor outflow in porcine eyes in an ex vivo model of glaucoma treatment.{27385}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • SR 3677 is a potent, ATP-competitive inhibitor of Rho-associated kinases (ROCKs) that shows greater potency against ROCK-II than ROCK-I in enzyme and cell-based assays (IC50 values are 3 and 56 nM, respectively).{27385} At 3 µM, SR 3677 inhibits only 5 (Akt3, Clk1, Clk2, Clk4, Lats2) out of 353 kinases with greater than 50% inhibition.{27385} SR 3677 is efficacious at inhibiting myosin light chain phosphorylation and increasing aqueous humor outflow in porcine eyes in an ex vivo model of glaucoma treatment.{27385}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • SR 3677 is a potent, ATP-competitive inhibitor of Rho-associated kinases (ROCKs) that shows greater potency against ROCK-II than ROCK-I in enzyme and cell-based assays (IC50 values are 3 and 56 nM, respectively).{27385} At 3 µM, SR 3677 inhibits only 5 (Akt3, Clk1, Clk2, Clk4, Lats2) out of 353 kinases with greater than 50% inhibition.{27385} SR 3677 is efficacious at inhibiting myosin light chain phosphorylation and increasing aqueous humor outflow in porcine eyes in an ex vivo model of glaucoma treatment.{27385}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • SR 3677 is a potent, ATP-competitive inhibitor of Rho-associated kinases (ROCKs) that shows greater potency against ROCK-II than ROCK-I in enzyme and cell-based assays (IC50 values are 3 and 56 nM, respectively).{27385} At 3 µM, SR 3677 inhibits only 5 (Akt3, Clk1, Clk2, Clk4, Lats2) out of 353 kinases with greater than 50% inhibition.{27385} SR 3677 is efficacious at inhibiting myosin light chain phosphorylation and increasing aqueous humor outflow in porcine eyes in an ex vivo model of glaucoma treatment.{27385}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • SR 4370 is an inhibitor of histone deacetylase 3 (HDAC3; IC50 = 6 nM).{47684} It is selective for HDAC3 over HDAC1, -2, -6, and -8 (IC50s = 0.13, 0.58, 3.7, and 2.3 µM, respectively). SR 4370 decreases viability of MDA-MB-231 human breast cancer cells with an IC50 value of 12.6 µM.  

     

    Brand:
    Cayman
    SKU:25543 - 1 mg

    Available on backorder

  • SR 4370 is an inhibitor of histone deacetylase 3 (HDAC3; IC50 = 6 nM).{47684} It is selective for HDAC3 over HDAC1, -2, -6, and -8 (IC50s = 0.13, 0.58, 3.7, and 2.3 µM, respectively). SR 4370 decreases viability of MDA-MB-231 human breast cancer cells with an IC50 value of 12.6 µM.  

     

    Brand:
    Cayman
    SKU:25543 - 10 mg

    Available on backorder

  • SR 4370 is an inhibitor of histone deacetylase 3 (HDAC3; IC50 = 6 nM).{47684} It is selective for HDAC3 over HDAC1, -2, -6, and -8 (IC50s = 0.13, 0.58, 3.7, and 2.3 µM, respectively). SR 4370 decreases viability of MDA-MB-231 human breast cancer cells with an IC50 value of 12.6 µM.  

     

    Brand:
    Cayman
    SKU:25543 - 25 mg

    Available on backorder

  • SR 4370 is an inhibitor of histone deacetylase 3 (HDAC3; IC50 = 6 nM).{47684} It is selective for HDAC3 over HDAC1, -2, -6, and -8 (IC50s = 0.13, 0.58, 3.7, and 2.3 µM, respectively). SR 4370 decreases viability of MDA-MB-231 human breast cancer cells with an IC50 value of 12.6 µM.  

     

    Brand:
    Cayman
    SKU:25543 - 5 mg

    Available on backorder

  • SR 48692 is an orally bioavailable allosteric antagonist of the neurotensin receptor NTS1 (Kd = 3.4 nM).{35296,35297} SR 48692 inhibits high affinity neurotensin binding to brain tissue from guinea pig, newborn mouse, newborn human, and adult human as well as rat mesencephalic cells and HT-29 cells with IC50 values ranging from 0.99 to 30.3 nM.{35296} It blocks neurotensin-induced intracellular calcium mobilization in HT-29 cells with a Ki value of 7.4 nM. SR 48692 (10 μM) inhibits NCI-H209 and NCI-H345 cell proliferation by approximately 70 and 80%, respectively.{35299} In vivo, SR 48692 (10 μg per day) reduces tumor volume and cell proliferation in an NCI-H209 mouse xenograft model. SR 48692 (80 μg/kg, p.o.) reduces contralateral turning induced by neurotensin (Item No. 24717) administration in mice by 85%.{35296} Daily administration of SR 48692 for five days in rats delays sensitization to the locomotor activating effects of cocaine during three additional cocaine challenges when given seven days prior to cocaine delivery but not under a cotreatment regimen.{35298}  

     

    Brand:
    Cayman
    SKU:20124 -

    Available on backorder

  • SR 48692 is an orally bioavailable allosteric antagonist of the neurotensin receptor NTS1 (Kd = 3.4 nM).{35296,35297} SR 48692 inhibits high affinity neurotensin binding to brain tissue from guinea pig, newborn mouse, newborn human, and adult human as well as rat mesencephalic cells and HT-29 cells with IC50 values ranging from 0.99 to 30.3 nM.{35296} It blocks neurotensin-induced intracellular calcium mobilization in HT-29 cells with a Ki value of 7.4 nM. SR 48692 (10 μM) inhibits NCI-H209 and NCI-H345 cell proliferation by approximately 70 and 80%, respectively.{35299} In vivo, SR 48692 (10 μg per day) reduces tumor volume and cell proliferation in an NCI-H209 mouse xenograft model. SR 48692 (80 μg/kg, p.o.) reduces contralateral turning induced by neurotensin (Item No. 24717) administration in mice by 85%.{35296} Daily administration of SR 48692 for five days in rats delays sensitization to the locomotor activating effects of cocaine during three additional cocaine challenges when given seven days prior to cocaine delivery but not under a cotreatment regimen.{35298}  

     

    Brand:
    Cayman
    SKU:20124 -

    Available on backorder

  • SR 48692 is an orally bioavailable allosteric antagonist of the neurotensin receptor NTS1 (Kd = 3.4 nM).{35296,35297} SR 48692 inhibits high affinity neurotensin binding to brain tissue from guinea pig, newborn mouse, newborn human, and adult human as well as rat mesencephalic cells and HT-29 cells with IC50 values ranging from 0.99 to 30.3 nM.{35296} It blocks neurotensin-induced intracellular calcium mobilization in HT-29 cells with a Ki value of 7.4 nM. SR 48692 (10 μM) inhibits NCI-H209 and NCI-H345 cell proliferation by approximately 70 and 80%, respectively.{35299} In vivo, SR 48692 (10 μg per day) reduces tumor volume and cell proliferation in an NCI-H209 mouse xenograft model. SR 48692 (80 μg/kg, p.o.) reduces contralateral turning induced by neurotensin (Item No. 24717) administration in mice by 85%.{35296} Daily administration of SR 48692 for five days in rats delays sensitization to the locomotor activating effects of cocaine during three additional cocaine challenges when given seven days prior to cocaine delivery but not under a cotreatment regimen.{35298}  

     

    Brand:
    Cayman
    SKU:20124 -

    Available on backorder